Association between hyperkalemia, RAASi non-adherence and outcomes in chronic kidney disease

BACKGROUND: Hyperkalemia is relatively frequent in CKD patients treated with renin-angiotensin-aldosterone-system inhibitors (RAASi). AIM: The aim of the present study was to estimate the increased risk of cardiovascular events and mortality due to sub-optimal adherence to RAASi in CKD patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Santoro, Antonio, Perrone, Valentina, Giacomini, Elisa, Sangiorgi, Diego, Alessandrini, Davide, Degli Esposti, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927011/
https://www.ncbi.nlm.nih.gov/pubmed/34115311
http://dx.doi.org/10.1007/s40620-021-01070-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927011/
https://www.ncbi.nlm.nih.gov/pubmed/34115311
http://dx.doi.org/10.1007/s40620-021-01070-6

Ejemplares similares